Medical Facilities Corporation (TSX: DR)

Medical Facilities Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	441.27	445.58	424.55	398.63	363.85	398.1
Revenue Growth (YoY)	-0.33%	4.95%	6.50%	9.56%	-8.60%	1.86%
Cost of Revenue	276.02	282.94	271.28	249.93	235.45	241.42
Gross Profit	165.25	162.65	153.27	148.71	128.4	156.68
Selling, General & Admin	71.12	74	70.86	57.68	58.73	60.14
Operating Expenses	90.79	95.54	91.62	84.45	86.62	89.93
Operating Income	74.47	67.11	61.65	64.26	41.79	66.76
Interest Expense	-13.17	-13.77	-12.89	-14.2	-14.35	-18.29
Interest & Investment Income	0.63	0.72	0.32	0.08	2.3	3.54
Earnings From Equity Investments	-	-0.32	-0.57	-0.13	-1.84	-0.1
Currency Exchange Gain (Loss)	-0.06	-0.03	-0	-0.03	-0.05	0.72
Other Non Operating Income (Expenses)	-17.69	-3.08	7.7	-12.19	-12.76	42.78
EBT Excluding Unusual Items	44.18	50.62	56.2	37.79	15.09	95.41
Impairment of Goodwill	-	-	-15.36	-	-	-22
Gain (Loss) on Sale of Assets	-	2.49	-	-	-	-
Asset Writedown	-	-	-1.19	-	-	-
Legal Settlements	-	-	-	-	-	0.9
Other Unusual Items	11.96	-0.79	-22.15	13.1	26.69	-2.6
Pretax Income	56.14	52.32	17.5	50.89	41.78	71.71
Income Tax Expense	3.3	8.33	5.21	4.4	4.36	12.03
Earnings From Continuing Operations	52.84	44	12.3	46.49	37.42	59.68
Earnings From Discontinued Operations	-	-	-	-	-1.74	-34.26
Net Income to Company	52.84	44	12.3	46.49	35.68	25.42
Minority Interest in Earnings	-33.31	-25.5	-16.7	-30.99	-26.87	-15.6
Net Income	19.53	18.5	-4.41	15.5	8.81	9.82
Net Income to Common	19.53	18.5	-4.41	15.5	8.81	9.82
Net Income Growth	265.21%	-	-	75.88%	-10.29%	-53.06%
Shares Outstanding (Basic)	24	25	29	31	31	31
Shares Outstanding (Diluted)	24	25	29	31	31	37
Shares Change (YoY)	-5.56%	-14.00%	-5.65%	0.07%	-16.04%	11.65%
EPS (Basic)	0.80	0.73	-0.15	0.50	0.28	0.32
EPS (Diluted)	0.80	0.73	-0.15	0.50	0.28	-0.42
EPS Growth	289.29%	-	-	78.04%	-	-
Free Cash Flow	73.9	56.66	50.3	67.22	105.76	64.81
Free Cash Flow Per Share	3.03	2.24	1.71	2.16	3.40	1.75
Dividend Per Share	0.259	0.244	0.238	0.230	0.220	0.759
Dividend Growth	7.78%	2.48%	3.64%	4.46%	-71.04%	-7.97%
Gross Margin	37.45%	36.50%	36.10%	37.30%	35.29%	39.36%
Operating Margin	16.88%	15.06%	14.52%	16.12%	11.48%	16.77%
Profit Margin	4.43%	4.15%	-1.04%	3.89%	2.42%	2.47%
Free Cash Flow Margin	16.75%	12.72%	11.85%	16.86%	29.07%	16.28%
EBITDA	83.99	77.95	71.58	80.86	59.55	87.1
EBITDA Margin	19.03%	17.49%	16.86%	20.28%	16.37%	21.88%
D&A For EBITDA	9.52	10.84	9.93	16.6	17.77	20.35
EBIT	74.47	67.11	61.65	64.26	41.79	66.76
EBIT Margin	16.88%	15.06%	14.52%	16.12%	11.48%	16.77%
Effective Tax Rate	5.88%	15.91%	29.75%	8.64%	10.43%	16.78%
Revenue as Reported	453.23	445.58	414.39	411.73	389.86	398.1

Source: S&P Capital IQ. Standard template. Financial Sources.